Article ID Journal Published Year Pages File Type
8537772 Pulmonary Pharmacology & Therapeutics 2018 25 Pages PDF
Abstract
The leukotriene receptor antagonist pranlukast can reduce airway inflammation and remodeling by inhibiting TGF-β/Smad signaling in an OVA-sensitized and -challenged asthma mouse model, thus suppressing AHR.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Pulmonary and Respiratory Medicine
Preview
The leukotriene receptor antagonist pranlukast attenuates airway remodeling by suppressing TGF-β signaling
Authors
, , , , ,